Related references
Note: Only part of the references are listed.HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production
Markus Toelle et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy
Sophie Van Linthout et al.
CIRCULATION (2008)
Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy
S. Van Linthout et al.
DIABETOLOGIA (2007)
High-density lipoprotein as a therapeutic target - A systematic review
Inder M. Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Vascular angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats
Michael D. Nyby et al.
HYPERTENSION RESEARCH (2007)
Endothelial function and dysfunction - Testing and clinical relevance
John E. Deanfield et al.
CIRCULATION (2007)
Increased insulin-stimulated expression of arterial angiotensinogen and angiotensin type 1 receptor in patients with type 2 diabetes mellitus and atheroma
Wassim Hodroj et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice
Jeong-Ho Oak et al.
DIABETES (2007)
Angiotensin II signal transduction through small GTP-binding proteins - Mechanism and significance in vascular smooth muscle cells
Haruhiko Ohtsu et al.
HYPERTENSION (2006)
Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes
M Burnier et al.
JOURNAL OF HYPERTENSION (2006)
Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages - A novel atherosclerotic effect of angiotensin II
Y Takata et al.
CIRCULATION RESEARCH (2005)
Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation
S Cai et al.
DIABETOLOGIA (2005)
Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase
K Chalupsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease
H Cai
CIRCULATION RESEARCH (2005)
Changes in plasma lipids during renin-angiotensin system blockade by combination therapy (enalapril plus valsartan) in patients with diabetes and hypertension
G Gaudio et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I
MA Creager et al.
CIRCULATION (2003)
Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells
FS Gragasin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector
S Van Linthout et al.
GENE THERAPY (2002)
Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia
G Lupattelli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
High-density lipoprotein restores endothelial function in hypercholesterolemic men
LE Spieker et al.
CIRCULATION (2002)
Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population
NN Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes
C Cheetham et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)